The collaborative study, which was sponsored by Norbrook, involved each practice blood testing a cohort of six lambs on 25 individual farms from 16 weeks of age, to look for evidence of antibodies to liver fluke.
Only 11 farms had positive results in the period from June, up to December, with most only showing one or two lambs out of the six sero-converting later in the year. Even farms located reasonably close by showed positive cases months apart.
Mark Thompson of Craven Farm Vets in Yorkshire said, “I did not expect to see positive results as late in the year. I expected a positive result earlier (September/October) as the farm is a very wet farm with a long-standing issue with fluke. Also, the weather in the area has been ideal for the intermediate host and fluke development on the pasture.”
Emily Baxter of Drove Farm Vets in Wiltshire said she thinks there is scope to use the results to improve the timing of dosing with flukicides and more responsible use: “We will use the results from this year’s testing to re-evaluate the farm’s fluke control protocol which will help reduce the level of use of flukicides earlier in the season for years with similar weather patterns and assist in planning of strategic grazing.
"We’re looking forward to continuing our work this year, no two years are ever the same, that’s why monitoring is so important. It will allow both ourselves and our clients to build up a picture over time of what’s happening not only on their individual farms, but potentially down to field level! This will allow us to provide more conclusive recommendations. For now, it’s clear that testing has great promise as a means to provide tailored advice to farms on how to control fluke and use the flukicides available to us responsibly.”
Emily says it’s important that farmers do not stop using flukicides based on the results of this study nor assume that there is less risk: “We all know how significant the losses from acute and chronic fascioliasis can be. We therefore encourage farmers to talk to their vet before they change their flukicide treatment protocols and discuss the possibility of using serology as an adjunct to determine how and when they treat.”
Veterinary professionals can find out more about the fluke sentinel project at https://xlvets-farm.co.uk/fluke-sentinel or the XLVets community at https://www.xlvets.co.uk/the-boss/.
Boehringer Ingelheim has released details of research presented at the 29th World Veterinary Congress which shows dogs with congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD) live longer when treated with pimobendan (Vetmedin®) compared with a commonly used ACE inhibitor.
The results of the QUEST trial, the largest international study of its kind to be conducted amongst dogs with congestive heart failure, are due to be published in the Journal of Veterinary Internal Medicine (JVIM) later this year.
The condition myxomatous mitral valve disease (MMVD) accounts for approximately 75% of all cases of CHF in dogs2. MMVD is associated with the thickening of the cusps of the mitral valve (one of the main one-way valves within the heart), affecting the flow of blood from the heart to the rest of the body. Although there is no cure for CHF due to MMVD, there are treatments available to manage the condition, improving the quality and length of the dog's life.
Professor Jens Häggström, lead investigator of the QUEST trial from the University of Uppsala, Sweden, commented that "the QUEST trial is a significant milestone in our efforts to reassure both, veterinarians and dog owners, that there is compelling evidence to show that pimobendan is an effective treatment for CHF that prolongs their dog's life and providing pet and owner with more quality time together."
The QUEST trial was a randomised, positive-controlled, multi-centre trial conducted at 28 sites across 11 countries, and is the largest study of its kind ever conducted in veterinary cardiology. The study compared a pimobendan group with a group treated with benazepril hydrochloride on top of background diuretic therapy. The trial spanned three years and followed dogs to death, euthanasia or treatment failure leading to withdrawal from the trial.
Research by Boehringer has also shown that over 50% of dog owners in the UK are unaware that their dog may be at risk of heart failure. Heart disease affects one in four dogs over seven years of age, and the lack of knowledge about this serious, life-threatening condition suggests that there is a need for better education amongst dog owners on how to recognise the disease, and how to maintain their dogs' heart health.
A new paper by D J Bartram and D S Baldwin, published in this week's Veterinary Record, has found that veterinary surgeons are four times as likely as the general public, and around twice as likely as other healthcare professionals, to die by suicide as opposed to other causes.
Professor Bill Reilly, President of the British Veterinary Association, said: "David Bartram's research in this difficult area is to be applauded. The more we can understand about the reasons behind the high suicide rate amongst veterinary surgeons, the more the BVA and other bodies can do to support vets in crisis.
"As part of the Vetlife Steering Group, the BVA supports fantastic initiatives such as the 24-hour Vet Helpline for vets, vet nurses and veterinary students, and the Veterinary Benevolent Fund.
"The BVA's Member Services Group (MSG) also spends a lot of time looking at practical initiatives to improve individual vets' day-to day lives. The recent introduction of the mediation and representation services to help resolve issues between veterinary employees and veterinary employers is a good example of the positive ways in which the BVA can support its members in difficult situations.
"The MSG also recently produced a helpline sticker for all veterinary practices to display on the medicines cabinet and other prominent places to act as a constant reminder that help is available.
"Ours is a small profession and many vets will know a friend or colleague who has taken their own life. It is essential that this issue is kept in the open so that those who are struggling know where to turn for help."
Bayer Animal Health, the maker of Veraflox, has produced a new animation which explains the considerations veterinary surgeons should take into account when choosing which antibiotic to prescribe.
The animation outlines the key steps that should be taken when faced with a suspected bacterial infection and includes factors such as culture and sensitivity testing, resistance and the mutant prevention concentration.
The company says it produced the animation in response to research it carried out last year in which nearly 500 veterinary professionals (465 practising vets and 45 students) participated.
48% said they felt that not enough is being done to educate veterinary professionals on the responsible use of antibiotics and how to avoid exacerbating the urgent issue of antimicrobial resistance.
Vicky McAlister, Group Product Manager at Bayer said: "In response to this research Bayer is developing a suite of educational resources to arm vets with practical and applicable tools that help them look beyond the 'tip of the iceberg' of bacterial infections, educating about not just the clinical cure, but bacteriological cure, too."
The animation is part of a wider awareness programme entitled ‘What Lies Beneath‘ in which Bayer says it aims to better understand the challenges the veterinary industry faces when prescribing antibiotics, so that additional tools can be developed to help vets confidently use antibiotics responsibly.
The programme will also include a series of webinars led by experts in various fields including veterinary medicine, laboratory diagnostics experts, behavioural psychologists and microbiologists. The webinars are due to be released later in the year, and will present a different perspective on common issues such as compliance, how to make appropriate antimicrobial choices and the approach to and interpretation of relevant diagnostic tests.
The College says that although professional bodies advise their members to value their own wellbeing and seek help if unwell, there has been an absence of senior professionals who have felt able to say 'been there myself'.
By asking senior medical professionals to share their stories of overcoming struggles with mental health, &me aims to encourage other medical professionals to seek help, in part by showing that such experiences do not exclude people from achieving leading roles in healthcare.
With the addition of Dr Cathy Wield in August, there are now seven ambassadors for the &me campaign, and all of their stories can be read at www.vetmindmatters.org/&me:
Lizzie Lockett, Director of the Mind Matters Initiative, said: "Over the past eight months we have seen an incredible level of support for our &me ambassadors. Our Facebook post about Rob Pettitt, for example, reached nearly 25,000 people, many of whom posted stories about Rob helping them navigate veterinary school and better understand their own mental health issues. These kind of role models really do help reduce stigma, and we thank every one of our ambassadors for having the courage to share their own experiences with mental health."
Louise Freeman, Vice-Chair of the Doctors’ Support Network, said: "The &me campaign has really shown how the medical professions can work together when it comes to mental health. Medical professionals face many of the same challenges, and we needn’t face them alone – instead we can work as one to tackle stigma and speak openly about mental health issues. And it’s not just in the UK that health professionals can feel as if they are ‘not allowed’ to experience mental health problems. As a direct result of the &me campaign, health professionals from around the world including Australia and the U.S. have been in contact with DSN to confirm that they have similar issues within their local health culture."
The campaign is still interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill health. To participate in the campaign, please email Dr Louise Freeman on vicechair@dsn.org.uk.
On social media tweets about the campaign are sent from @vetmindmatters and @DocSupportNet twitter accounts using the hashtag #AndMe.
The RCVS has launched its new Fellowship scheme and is now accepting applications from veterinary surgeons who have made a meritorious contribution to their particular field.
The new Fellowship scheme was launched with three routes to membership: meritorious contributions to knowledge; meritorious contributions to clinical practice; and meritorious contributions to the profession.
The changes were approved by RCVS Council at its June 2015 meeting, following a public consultation on how the Fellowship could be developed to move it away from being an examination-based award, to becoming a learned society.
Dr Bradley Viner, President of the RCVS, said: "I am very proud to announce the launch of the new Fellowship scheme and I hope that, as a learned body, the Fellowship will help advance and develop clinical and professional standards by sharing their knowledge and expertise with the profession.
"The move from being an examinations-based award to the three new paths to entry is a significant development as it will widen the reach of the Fellowship, particularly to those who are working in clinical practice.
"I would strongly encourage all those who feel they have made a meritorious contribution to any of these three areas to apply as I am very hopeful we will be able to award our first group of new Fellowships at RCVS Day on Friday 15 July."
The criteria for achieving Fellowship includes sustained contribution to scholarship; producing a body of creative work that has been disseminated to others; indisputable advancement of their subject; providing leadership to the profession; and, advancement of the public understanding of the profession.
Each application will be assessed by a Credentials Panel to see if it meets the proposed criteria. Applications approved by the Panel will then be put to the Fellowship Board, which will meet once a year to consider the overall list of proposed applications.
The closing date for initial applications is Wednesday 11 May. Application forms for the three different routes to Fellowship, as well as further details about criteria and a list of relevant doctorate programmes, can be found at www.rcvs.org.uk/fellowship
All current Fellows, including Honorary Fellows, will retain their FRCVS/HonFRCVS status.
The training sessions are taking place both online and in person and places will be allocated on a first come first served basis.
Upcoming training dates are as follows:
https://www.vetmindmatters.org/training/
Niall, who stepped up from Vice Chair to acting interim Chair of the Fellowship Board after the resignation of the previous Chair, has been formally elected as Chair of the Board.
In his role as Chair, Niall will continue to lead the Board, which is responsible for setting the criteria for joining the Fellowship across all three of its routes to entry, as well as the process by which applications are assessed.
An election for the position of Vice Chair of the Fellowship Board will take place in the autumn.
Niall said: “I am honoured beyond words to be elected Chair of the RCVS Fellowship and I'm very grateful for the support received to achieve this.
“I know I have very big shoes to fill, thanks to the great efforts that have gone on before and I will put all my available energy into continuing to work with our Fellows and the College to progress the goals of RCVS Fellowship as a resource of independent knowledge for our professions, to upskill and always innovate, while looking to enrich public awareness and discussion.”
Nicky Paull MRCVS, who has held the position of Chair of the Credentials Panel for the Meritorious Contributions to Clinical Practice pathway for the past three years, was successfully re-elected.
Nicky will continue to be responsible for making assessments of applicants aiming to gain Fellowship through the Meritorious Contributions to Clinical Practice pathway.
She will co-ordinate and oversee a review of the applications by her fellow panel members, as well as chairing any required appropriate panel meetings.
On her appointment, Nicky said: “I look forward to the challenge of continuing to grow the diversity of the Fellowship and celebrate those who, by their contribution to the advancement of the profession by clinical or educational scholarship and leadership, have had a significant impact on clinical practice within the veterinary profession.”
Niall and Nicky will be formally instated into their roles at Fellowship Day, which is due to take place on Thursday 28 November at One Great George Street, London.
https://www.rcvs.org.uk/fellowship/
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
Vets Now, the out-of-hours emergency services provider is to launch the Vets Now Hospital service in Glasgow city centre, where it will offer emergency and critical care together with a range of specialist referral options.
This follows on the heels of The University of Glasgow Small Animal Hospital, a new £15 million facility which opened at the end of August.
Vets Now says that the new hospitals and the range of clinical services on offer to the profession and pet owners will make the west of Scotland a centre of excellence in advanced clinical care for animals.
The opening of the two facilities will also offer both organisations a new platform on which to develop further their long standing relationship through future collaboration in the areas of teaching, training and investigation into animal disease.
Vets Now Group Managing Director, Richard Dixon said: "The opening of the two facilities presents a number of opportunities for both organisations to work collaboratively to develop teaching and training for undergraduates, residents, interns and nurses, and to work together to gain further understanding into animal disease through clinical investigation and the practice and promotion of evidence based medicine."
Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University said: "The expanded service which will be offered by the Small Animal Hospital and the new Vets Now Hospital obviously presents an enhanced range of choices for pet owners and first opinion vets in Scotland and an opportunity for both organisations to work collaboratively to ensure that undergraduates and clinical professionals have access to the best training and opportunities to develop professionally. We have enjoyed a mutually beneficial relationship for a number of years and we look forward to the new opportunities which the opening of the two hospitals will bring in the future."
The Small Animal Hospital opened on 31 August. The first Vets Now Hospital will open in Glasgow on 31 October.
US veterinary equipment manufacturer Midmark is holding a draw for a Matrx VMS anaesthesia machine, open to all UK veterinary practices.
Click this link, enter your details, and the winner will be announced on 7th July 2010.
The Animal Health Trust's (AHT) Dr Sue Dyson has been awarded a place in the International Equine Veterinarians Hall of Fame, in recognition of her contribution to hoof care in horses.
Sue, who is Head of Clinical Orthopaedics at the AHT, has lectured internationally and is known for both her clinical work with horses and an extensive research record, having published more than 200 refereed papers on lameness and diagnostic imaging in scientific journals. She has also co-authored several veterinary textbooks as well as training and competing as a high-level rider in international events.
Established in 1997, the International Equine Veterinarians Hall of Fame honours veterinary surgeons who have contributed to the knowledge and recognition of proper hoof care for horses. Vets are nominated either as practicing equine vets who work closely with farriers in the field, or as college and industry vets involved in teaching, research or other important aspects of equine veterinary and hoof care.
Anyone can nominate an equine vet for the award, which is sponsored by the American Farriers Journal, but selection is completed by previous inductees into the International Equine Veterinarians Hall of Fame. Awards are presented each year during the International Hoof-Care Summit in Cincinnati, Ohio.
Sue said: "I was completely surprised, but absolutely thrilled, to learn that I had been selected to join the distinguished list of people who have previously been appointed to the International Equine Veterinarians Hall of Fame.
"I think it is very humbling to recognise that, despite the knowledge that my team and I have amassed in the last 30 years, there is so much more to learn. From every new finding come many more questions. I hope that the enthusiastic dedication of my team will continue to result in learning and discovering more, and inspire others to do likewise, to the ultimate benefit of the welfare of our great friend, the horse."
Sue has has worked at the AHT for 30 years and is currently researching the association between hindlimb lameness and saddle slip. She has observed some association between the two for several years, however saddle slip has traditionally been attributed to an ill-fitting saddle, asymmetry of the horse's back shape or a crooked rider.
In 2011 Sue carried out a prospective research project with Intern Line Greve: 'Saddle slip may be an indicator of the presence of hindlimb lameness'. It was presented at the 51st Annual Congress of the British Equine Veterinary Association, Birmingham 2012, and identified that in some cases, saddle slip was directly linked to the presence of hindlimb lameness.
Research results showed that of 128 horses assessed for lameness grade and degree of saddle slip when ridden by two riders, the saddle consistently slipped to one side in 54% of the horses with hindlimb lameness, in comparison to just 4% of the horses with forelimb lameness. Diagnostic analgesia to abolish the hindlimb lameness eliminated the saddle slip in 97% of the horses observed in the study.
Sue and Line are currently undertaking further research to measure movement of the back, and forces under the saddle, with the aim of explaining biomechanically what is happening during the occurrence of saddle slip.
The 45-minute webinar: Debt Management: Prevention Is Better Than Cure is presented by Mike Brooks from veterinary-specialist debt recovery agency, dsl.
VPMA President Renay Rickard (pictured right) said: "Debt can affect any business, but, because of the role vets play as care-giver in an emotionally-based animal-owner relationship, we are particularly vulnerable. This is something that is commonly brought up by members at our regional meetings and events, and it’s a real dilemma for them how to juggle being strict with payment policies against owner expectations and misperceptions of the cost of veterinary medicine.
"This has been a very popular topic in both our regional meetings and with our webinar and we wanted to open it up to more people to help them tackle this topic in their practices. The feedback on this webinar has been very positive. Mike gives clear guidance on how to set up payment protocols that will minimise debt in such a way that maintains the client-practice relationship. There’s also information on how to recover existing debts. It makes sense to prioritise tackling this issue as if we’re not paid, then we can’t deliver the service that we are expected to, and that our patients need.
"We’re pleased to open this webinar up to all practices as a Christmas gift, and hope it will also highlight the support that is available through VPMA membership."
The webinar can be accessed through a link on the home page of the VPMA website www.vpma.co.uk.
Following stock challenges earlier in the year, the company is now urging vets to encourage farmers to vaccinate their flocks to prevent abortions during lambing.
Roy Geary, regional director for Northern Europe at Ceva Animal Health, said: “While we realise that the temporary delay of Cevac Chlamydia has been inconvenient to our valued sheep farmers we would like to thank all our customers for their patience and support during this challenging time.
"The vaccine supply is now available in the UK for the latter end of the season.
"Farmers tupping later in October should therefore be encouraged to vaccinate their flocks to protect their ewes from this devastating disease.”
www.enzooticabortion.co.uk
Dechra Veterinary Products has announced the appointment of Bob Parmenter as managing director of its UK business.
Commenting on his appointment, Bob said: "I'm pleased to have joined Dechra at a very exciting stage of the company's development. I've been following the growth of Dechra over recent years and with its acquisition of VetXX in January, I believe that the business is now strongly placed to further establish itself as a leading player in the animal health industry."
Having spent nearly 40 years in the industry, Bob Parmenter has previously worked for Schering-Plough, Mallinckrodt Veterinary, Pitman-Moore, Coopers Animal Health and ICI Pharmaceuticals. "My career path has enabled me to experience all aspects of the animal health market. I'm confident my industry-wide knowledge will provide Dechra with additional experience as we continue to build our reputation and strengthen our UK market position."
Former MD Giles Coley, who joined Dechra in 1999 and has managed the UK business since 2003, has been promoted to European Pharmaceutical and Export Sales Director. As a member of Dechra Veterinary Product's European Board he will be responsible for co-ordinating pharmaceutical sales across Europe and developing the company's export sales.
Vygon Vet, a division of Vygon (UK) Ltd, has announced the launch of its website - www.vygonvet.co.uk.
Vygon has been supplying the veterinary market for 15 years. The new website means the company's products can now be bought direct online. The range includes: Vascular Access, IV Management, Needle-Free Devices, Respiratory, Digestive Tract, Regional Anaesthesia, Tissue Adhesive, Urinary & Rectal Tract and Theatre Products.
In addition to product information and technical data, the website offers guidance notes and tips about basic procedures.
Les Davies, Managing Director of Vygon (UK) Ltd said: "The launch of the new website demonstrates our commitment to the veterinary market and we hope that it not only enables veterinary professionals to order our products with ease, but that they also find the guidance notes and advice a valuable resource for their practice."
Vygon Vet products can also be ordered by telephone or through your veterinary wholesaler.
The RCVS Council has announced its agreement with wholesale reform of the College’s governance arrangements to improve the efficiency and accountability of its decision-making processes.
The changes agreed by Council included almost halving the number of Council members and formalising lay and veterinary membership.
Under the proposals approved by Council it would be reduced to 24 members – comprising 13 elected veterinary surgeons (constituting a majority of Council), six appointed laypeople, three members appointed on behalf of the UK veterinary schools and two veterinary nurses. There would also be the option to appoint an additional member on behalf of any allied professions that RCVS Council may choose to regulate as associates of the College.
Professor Stuart Reid, Senior Vice-President of the RCVS and Chair of the Governance Panel that developed the recommendations, said: "I am delighted that Council so fully supported our proposals for a new structure. The new composition will ensure that both veterinary nurses and laypeople have a guaranteed place at the Council table, as well as maintaining a majority of elected veterinary surgeons and important input from the veterinary schools.
"The proposal recognises the unique nature of the RCVS and will allow us to expedite our decision-making process, making us more fleet of foot and better able to respond to the needs of the profession and the public. It has also been constructed to allow Council to evolve its position, ensuring it remains relevant into the future. If all goes well we hope that the changes could come into force as soon as March 2017."
Liz Cox, the Chair of VN Council, particularly welcomed the changes in respect of veterinary nursing representation on RCVS Council, adding: "It is an historic decision for veterinary nurses and one that has been long awaited. It is only right that those who work so closely alongside veterinary surgeons in practice should have a direct input into regulation that affects us all."
Council’s approval of the recommendations was the culmination of two years of debate and consultation with the profession and other stakeholders. This included a formal consultation by the Department for Environment, Food and Rural Affairs (Defra) last year which garnered 52 responses – including from the British Veterinary Association - most of which were supportive. Different options for reform had, in turn, been developed by a Governance Panel, chaired by Professor Reid, which was set up by Council in March 2015 to consider various options.
Defra will now run a short informal consultation to provide those who responded to the initial consultation the opportunity to comment on the proposed reforms. If no issues are raised Defra officials will seek approval from the Government to proceed with a legislative reform order (LRO) to make the necessary changes to the Veterinary Surgeons Act.
This LRO will be scrutinised by parliamentary committee and voted on in both the House of Commons and House of Lords. Once this has been passed there will be a three-year transitional period, agreed by Council members, during which Council’s numbers would be gradually reduced.
The deadline for nominations for Practice of the Year, Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff of the Year, is 16th January.
The award ceremony will take place on 2nd April 2020 in Birmingham.
James Barnes, Head of Sales & Partnerships at Petplan, said: "We’ve been recognising the brilliant work of the UK’s veterinary professionals through the Petplan Veterinary Awards for 21 years now and every year the standard of entries just gets higher.
"The nominations are a testament to the hard work of all of those involved at practices who care for animals and clients all year round.
"The awards are a perfect opportunity for you to showcase your practice and your colleagues. Being acknowledged is great for team morale and a wonderful opportunity to raise the profile of the practice to new and existing clients alike. If you haven’t already I’d invite you to nominate someone today!"
You can nominate a colleague or your own practice at petplanvet.co.uk/vetawards, before nominations close on 16th January 2020.
Topics include applying the principles of antimicrobial stewardship (AMS), making confident diagnostic and prescribing decisions, and managing client expectations around antibiotic use within practice.
In the first episode, Tim explores how to apply the principles of AMS in the consulting room, starting with recognising when antibiotics are genuinely needed.
He explores the role of clinical signs and cytology in guiding diagnosis and treatment decisions, while also emphasising the risks of unnecessary prescribing.
The discussion also covers when empirical antibiotic use may be appropriate and how to ensure these decisions are justified.
Each episode offers practical, evidence-based insights which Krka says can be easily implemented in general practice.
The series is accompanied by downloadable Vet2Vet Insights information sheets that summarise the main take-home messages from each episode.
https://open.spotify.com/show/0uphORU03q29WncwmN2EIa
The information sheets are available here: https://www.krka.co.uk/veterinary-knowledge-hub/articles/responsible-use-of-companion-animal-antibiotics
Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already widely used in human medicine. It is increasingly being used in the treatment of horses.
The Osteokine system, developed by German company Orthogen which also manufactures joint therapy Irap, comprises two interconnected blood bags.
The system involves taking citrated whole blood from the horse and placing it into the first, red-capped Osteokine bag for processing in a centrifuge. The plasma and platelets are then transferred to the second bag, and a second centrifuge process separates the plasma and generates a pellet of PRP, which is extracted and used to treat the horse from which it was taken.
Treatment with PRP has been shown to accelerate wound healing in all kinds of tissue particularly tendons and ligaments and has also been used in bone healing. It has been noted to reduce perioperative traumatic pain while the higher collagen content provided by PRP can create improved scar resistance.
Commenting on the launch of the Osteokine system in the UK, Rob Watkins, Marketing Director of Genitrix, said: "Therapeutic care of equine lameness is an area of particular expertise for Genitrix and the innovative treatments we've brought to market, including Acell, HY50 and Irap already form part of the staple ‘toolkit' of many equine vets.
"The benefits of PRP in terms of accelerating wound healing and vasculerisation are already widely accepted as are the advantages of an autologous approach in terms of eliminating the risk of disease transmission. To date, however, the process of extracting PRP has proved complex and expensive and only provided in specialised laboratories.
"Osteokine, in contrast, offers a cost-effective approach based on a system which is simple to operate in practice and takes only 20 minutes. We believe it offers a highly effective approach to treating wounds and injuries in horses."
For further information on Osteokine, contact Genitrix on 01403 786345.
The Bella Moss Foundation (BMF) is to launch the Human to Animal MRSA Advice Service at the offices of the British Veterinary Association on Friday 22nd October.
The charity says this new online service has been created to provide information and advice on resistant bacteria and their effects on animal health to veterinary professionals, pet owners and carers.
BMF clinical advisor David Lloyd, professor of veterinary dermatology at the Royal Veterinary College, said: "There has been a worrying increase in the numbers of pets reported with MRSA Infections. The causes for this seem to be complex, and research to understand this emerging infection in animals and people is continuing. The Bella Moss Foundation has been very helpful explaining to pet owners the complexity of these issues, and the new Animal MRSA Advice Service will be an educational tool for lay people and veterinarians to learn more about resistant bacterial infections in animals."
For pet owners and carers the Animal MRSA Advice Service will provide education on bacteria, the risk factors for transmission between humans and animals, keeping pets healthy, finding a vet, and the importance of hand hygiene in protecting pets and people from unwanted infection.
For veterinary professionals and practice staff the service will also provide academic reports and international research, as well as information on CPD seminars.
If you would like to attend the launch of this new service, please contact info@thebellamossfoundation.com, or call Jill Moss on 07581 736774.
Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.
The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".
Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.
Hill's Pet Nutrition and Cat Professional are working in partnership to improve knowledge of feline lower urinary tract disease by giving complimentary copies of 'Caring for a cat with lower urinary tract disease' by UK feline specialists Dr Sarah Caney and Professor Danièlle Gunn-Moore to veterinary professionals and owners of cats affected by the condition.
Feline lower urinary tract disease is thought to affect up to 10% of cats, with particular prevalence in the indoor cat population and it is often a complex and distressing condition for cat owners to tackle.
Hill's has sponsored 1000 copies of 'Caring for a cat with lower urinary tract disease' , and is giving away vouchers which allow the recipient to visit the Cat Professional website (http://www.catprofessional.com/) to download an interactive copy of the book.
'Caring for a cat with lower urinary tract disease' is the third title in the successful 'Caring for a cat' series. Renowned cat behaviourist and bestselling author, Vicky Halls reviewed the book in glowing terms: "Feline lower urinary tract disease is a complicated subject for owners to fully appreciate so it is wonderful, at last, to have one book that contains all the necessary information that can be recommended to everyone"Hill's Pet Nutrition are distributing the complimentary vouchers to owners who contact their customer service freephone line for advice on the condition (0800 282438 - 9am - 4pm, Monday to Friday). Veterinary Professionals using the free Urolith Analysis Service offered by Hill's, or the Hill's Veterinary Technical Enquiry Line to gain help and advice on nutritional management of Feline Lower Urinary Tract diseases are also able to claim a complimentary voucher to redeem.
Adrian Pratt, Veterinary Affairs Manager for Hill's comments "FLUTD is a difficult disease to manage, let alone explain to fully to an owner. What Sarah and Danielle have done here is fantastic and will help owners better understand their cat's problem. That can only be good for the pet"